In a series of 70 patients who underwent tumorectomy or mastectomy for invasive ductal carcinoma (IDC) with concomitant ductal carcinoma in situ (DCIS), 91% were positive for NTR1, with a threshold of 10% stained cells. The gene discussed is NTSR1; the disease is ductal breast carcinoma in situ.